Fred Hutchinson Cancer Center
Birthplace of bone marrow transplantation (Thomas, Nobel 1990) and a CAR-T pioneer (Riddell).
Transplant, CAR-T (Juno origins), HPV vaccine trials, SWOG statistical centre, Hutch Cancer Immunotherapy Integrated Research Center.
- Transplant
- CAR-T
- SWOG
Virologist whose HPV research underpinned the vaccines that are eliminating cervical cancer.
Paediatric oncologist who chairs the world's largest childhood cancer research organisation.
Gary Lyman is an oncologist and health economist behind guidelines on growth factors, thrombosis, and biosimilars in cancer care.
Hans-Peter Kiem is a gene and cell therapy researcher working on editing blood stem cells inside the body.
Michael LeBlanc is the statistician behind SWOG's trials, based at Fred Hutch's statistical centre.
Immunologist who spent four decades engineering T cells to attack leukaemia and solid tumours.
Sara Hurvitz is a breast cancer trialist who led DESTINY-Breast03, the trial where Enhertu beat Kadcyla.
Adoptive T-cell therapy pioneer whose defined-composition CAR-T work led to lisocabtagene maraleucel.
Thomas Lynch is a lung cancer oncologist who co-discovered EGFR mutations and now leads Fred Hutch.
Pages like this
not linked directly; found by shared links- TrialPonsegromab phase 2 in cancer cachexia
- PathwayJAK–STAT signalling
- TargetMesothelin
Shares Philip D. Greenberg, CAR-T cell therapy.
- ProductLisocabtagene maraleucel
Shares Stanley R. Riddell, CAR-T cell therapy.
- PathwayAntigen presentation & immune editing
Shares Shared splice-derived neoantigens as off-the-shelf vaccine targets, RNA splicing, CAR-T cell therapy.
- InstitutionCold Spring Harbor Laboratory
- TechnologyIn vivo CAR-T
Shares Hans-Peter Kiem, CAR-T cell therapy.